Literature DB >> 24589529

Validation of the Thermor BIOS BD215 device for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010.

Elisabetta Benetti1, Claudio Fania, Verónica Márquez Hernández, Paolo Palatini.   

Abstract

The objective of this study was to determine the accuracy of the Thermor BIOS BD215 device for home blood pressure (BP) measurement according to the International Protocol of the European Society of Hypertension (ESH). Device evaluation was carried out in 33 patients. The mean age of the patients was 57.0 ± 15.0 years, the mean systolic BP was 142.0 ± 20.3 mmHg (range 100-177 mmHg), the mean diastolic BP was 88.0 ± 14.6 mmHg (range 48-123 mmHg), and the mean arm circumference was 28.0 ± 3.0 cm (range 24-33 cm). The protocol requirements were followed precisely. The device passed all requirements, fulfilling the standards of the protocol. On average, the device overestimated the systolic BP by 0.6 ± 4.2 mmHg and underestimated diastolic BP by -0.5 ± 3.2 mmHg. The device-observer discrepancies were unrelated to patients' clinical characteristics. These data show that the Thermor BIOS BD215 device fulfilled the requirements for validation by the International Protocol and can be recommended for clinical use in the adult population.

Entities:  

Mesh:

Year:  2014        PMID: 24589529     DOI: 10.1097/MBP.0000000000000030

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  2 in total

1.  Protocol of the Swiss Longitudinal Cohort Study (SWICOS) in rural Switzerland.

Authors:  Andreas W Schoenenberger; Franco Muggli; Gianfranco Parati; Augusto Gallino; Georg Ehret; Paolo M Suter; Renate Schoenenberger-Berzins; Therese J Resink; Paul Erne
Journal:  BMJ Open       Date:  2016-11-28       Impact factor: 2.692

2.  The QardioArm App in the Assessment of Blood Pressure and Heart Rate: Reliability and Validity Study.

Authors:  Victoria Mazoteras Pardo; Marta E Losa Iglesias; José López Chicharro; Ricardo Becerro de Bengoa Vallejo
Journal:  JMIR Mhealth Uhealth       Date:  2017-12-15       Impact factor: 4.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.